Login
Navigate Fool.com
Will AUXL beat
the market?
Community Rating: 3 Stars: Appealing

19.35 -0.09 (-0.46%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $19.58
Previous Close $19.44
Daily Range $19.17 - $19.77
52-Week Range $16.36 - $32.89
Market Cap $972.5M
P/E Ratio -14.73
Dividend (Yield) $0.00 (0.0%)
Volume 450,131
Average Daily Volume 1,828,777
Current FY EPS -$0.59

How do you think AUXL
will perform against the market?

Top AUXL Bull/Bear Pitches

 

mblin13 (< 20)
Submitted March 1, 2007

downside provided by testim; other drugs in phase 3 trials; stock could triple

0 Replies Reply Report this Post
 

TMFBlacknGold (< 20)
Submitted June 29, 2012

This came up in a screen for stocks with the highest gains in the last 4 weeks. With a fair book value of $1.83 this company is greatly overvalued - although that is expected in speculative pharma. It … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

Would You Support U.S. Companies Making This "Un-American" Move?

Corporate tax inversion is becoming endemic in the health care industry. Where do you stand after viewing both the positive and negative implications of this tax-fleeing corporate strategy?

Auxilium Pharmaceuticals Inc Joins the Buyout Bonanza

Auxilium's acquisition of QLT guarantees dilution but could produce tax benefits down the road if profits improve

Why Auxilium Pharmaceuticals Wants QLT, Inc.

Small deal, but part of a larger trend.

Closing Update: Stocks Work to Erase Early Declines, Stop Just Short of Breaking Even as Spending, I

Closing Update: Stocks Work to Erase Early Declines, Stop Just Short of Breaking Even as Spending, Income Worry Investors

Sector Update: Healthcare Stock Pare Losses Near Closing Bell; Coronado Biosciences Slips as Prospec

Sector Update: Healthcare Stock Pare Losses Near Closing Bell; Coronado Biosciences Slips as Prospective Autism Drug Stalls in Testing

Why QLT Inc. Stock Rocketed Higher

QLT shares soar after agreeing to be purchased. Find out how this could affect existing QLT shareholders and investors of the purchasing company.

Biotech Stocks to Watch Today: Agenus, Allergan and Auxilium Pharmaceuticals

Today's top stories in biotech and health care.

Mid-Afternoon Market Update: ULTA Salon Remains Steady After Strong Results; Orexigen Still Down 15%

Mid-Day Market Update: ULTA Salon Rises After Strong Results; Orexigen Shares Slide

Why Auxilium Pharmaceuticals, Inc. Shares Could Fly 15%

Does this analyst make a good case? Or is it just more noise from Wall Street?

See More AUXL News...

Sector

Healthcare

Industry

Drugs

Auxilium Pharmaceuticals, Inc. (AUXL) Description

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians. Website: http://www.auxilium.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks